Researchers are inviting individuals with a #SCN1B genetic variant to take part in a short online survey to learn more about the experiences of people with SCN1B.

Want to help? Complete the 10‑minute survey: https://redcap.link/ftykr35s

#EpilepsyResearch #RareDisease #Genetics

Mark Bowren, PhD was awarded the 2026 Susan S. Spencer, MD Next Generation Research Grant in Epilepsy. Dr. Bowren will work to improve brain mapping for patients with epilepsy by using a technique called ultra-high frequency stimulation to temporarily pause signaling between brain regions. This insight has the potential to help make brain surgery safer for patients and improve their long-term quality of life. This research is co-funded by the American Epilepsy Society & the Epilepsy Foundation.

Mark Bowren, PhD was awarded the 2026 Susan S. Spencer, MD Next Generation Research Grant in #Epilepsy.

Institution: University of Iowa
This research is co-funded by @amepilepsysoc.bsky.social & @epilepsyfoundation.bsky.social.

More ➡️ buff.ly/yR8iTVi
#EpilepsyResearch

Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy

Fantastic news for families: A groundbreaking new drug is showing incredible promise in treating children with a devastating form of epilepsy! This could be a life-changing breakthrough. #EpilepsyResearch #ChildHealth #HopeForKids 💜

Zhao et al. show that combining machine learning with #miRNA #biomarkers can diagnose epilepsy with up to 95.45% accuracy, offering a promising non-invasive alternative to traditional EEG methods. doi.org/10.4103/ATN.... #EpilepsyResearch #MachineLearning #Neurology #MedTech #MedSky #neuroskyence

PRIME Researchers publish Nature Journal Publication: Modeling the microRNA regulation of TGF-β/SMAD signaling pathways for seizure control in temporal lobe epilepsy. The paper ‘Modeling the microRNA Regulation of TGF-β/SMAD Signaling Pathways for Seizure Control in Temporal Lobe Epilepsy’ written by Walton Institute at South East Technological University’s Kurt J....

EU FET OPEN PRIME researchers have published a new paper in Nature Publication Journal. Congratulations to Kurt J. Pumares, PhD student @waltoninstitute.bsky.social and fellow #PRIME consortium partner co-authors. Read more: fet-prime.eu/prime-resear... #EpilepsyResearch

For International Epilepsy Day, we spoke with collaborators about closing the epilepsy treatment gap.
In this video, Professor Arjune Sen is joined by Dr Neerja Chowdhary, Dr Gift Wilson Ngwende and Action Amos.

Watch the video here: youtu.be/68RdlbFMtbk

#InternationalEpilepsyDay #EpilepsyResearch

On #InternationalEpilepsyDay, we highlight how AI is changing the game by transforming brain wave monitoring, imaging analysis and treatment decisions.
Explore how AI is reshaping epilepsy care in this must-read journal: www.academax.com/WJP/doi/10.1...
#ArtificialIntelligence #EpilepsyResearch 🌐🧪

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow | NeurologyLive - Clinical Neurology News and Neurology Expert Insights Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

🧠✨ Promising news in Dravet syndrome: Phase 3 EMPEROR results for zorevunersen are now expected by mid-2027, with an FDA NDA planned soon after. A potential step toward disease modification.

Read more: www.neurologylive.com/view/phase-3...
#Dravet #EpilepsyResearch #RareDisease #Biotech #Neurology

New in Epilepsia – January 10, 2026
mailchi.mp/ilae/new-art...

Subscribe - eepurl.com/iLSrNc

#epilepsy #epilepsia #ILAE #EpilepsyResearch #NewInEpilepsy #JustPublished #LatestResearch

Ontario Brain Institute - Controlled Data Release: The Epilepsy Research Program (EpLink)

Now on Brain-CODE: New EpLink dataset on temporal lobe #epilepsyresearch to predict surgical outcomes + cognitive side effects.

Led by @uhnresearch.ca & @westernu.ca researchers, connecting brain features with outcomes for AI-driven personalized care.

🧠 More: braininstitute.ca/news-events/...

Timing is everything: Expert opinion on researching epilepsy rhythms by the ILAE Task Force on Chronobiology.
Baud, Maxime O et al.
Paper
Details
#EpilepsyResearch #Chronobiology #ILAETaskForce

🔬 We are also hiring!

We are looking for a PostDoc interested in translating machine learning to clinical neuroscience & data integration.

📍 Vienna | 🕒 Full-time | 🗓 Start: February 2026
📨 Apply until 20.01.2026: epiconn@meduniwien.ac.at

#ScienceJobs #EpilepsyResearch #ClinicalNeuroscience

🚀 EPICONN has launched!

Towards Epileptomics: a connectome-based approach to predictive & personalized treatment for focal epilepsy. Together we are building an interdisciplinary team and will shape the future of network-based, personalized epilepsy care.
#EPICONN #EpilepsyResearch #MedUniWien

Research Discovery: CRISPR can be used to stop seizures in mice (and potentially human children) who have a mutation in one of their two SCN2A genes.

Diseases Affected: SCN2A haploinsufficiency, epilepsy, neurodevelopmental delays, and autism.

Key Findings: CRISPR gene editing was used to increase the protein production of the healthy SCN2A gene, to compensate for the defective gene. This restored normal levels and signaling that stopped the seizures from happening.

What’s Next? While the experiment was successful in mice, the researchers caution that too much of any protein can be dangerous. More work is needed to determine the safety of this type of treatment for humans.

Scientists at UCSF Weil Institute for Neurosciences used CRISPR to stop #seizures in mice. Human children with SCN2A haploinsufficiency often have #epilepsy and neurodevelopmental delays. But boosting the healthy gene’s protein production might be a solution. #EpilepsyResearch

Scientists Quiet Epileptic Seizures by Clearing Aging Brain Cells Clearing out “aged” brain cells dramatically reduced seizures and restored memory in a new epilepsy study. Temporal lobe epilepsy is a neurological condition marked by repeated seizures and problems...

Scientists Quiet Epileptic Seizures by Clearing Aging Brain Cells #Science #HealthandMedicine #Neurology #EpilepsyResearch #BrainHealth #Neuroscience

New in Epilepsia – December 13, 2025
mailchi.mp/ilae/new-art...

Subscribe - eepurl.com/iLSrNc

#epilepsy #epilepsia #ILAE #EpilepsyResearch #NewInEpilepsy #JustPublished #LatestResearch

Febrile Seizures – CURE Epilepsy Seizure types are classified by where they begin in the brain, consciousness changes, and symptoms. Learn how each type presents and is managed.

Our febrile #seizures overview provides a clear summary of febrile seizure types, causes, risk profiles, diagnostic considerations, and current understanding of recurrence and future epilepsy risk. Learn more: https://bit.ly/4pZozN2

#epilepsyresearch #neurology #pediatrics

Genomic sequencing is transforming #epilepsy care, revealing monogenic/polygenic causes, risk modifiers, and key pharmacogenomic insights
#EpilepsyResearch #Genomics #PrecisionMedicine
onlinelibrary.wiley.com/doi/10.1111/...

Ozempic Shows a Possible Hidden Effect on Epilepsy Risk GLP-1 drugs like Ozempic, Trulicity and Victoza were associated with a slightly lower likelihood of developing epilepsy in a large group of people with type 2 diabetes. GLP-1 drugs may be connected to...

Ozempic Shows a Possible Hidden Effect on Epilepsy Risk #Science #HealthandMedicine #Neurology #EpilepsyResearch #Ozempic #HealthEffects

Depression not only makes epilepsy harder to treat but may also raise the risk of developing it, new research finds.

youtu.be/fR33zWOb1DY

#Epilepsy #Depression #MentalHealth #BrainHealth #SeizureDisorders #EpilepsyResearch #Neurology #MentalHealthAwareness #ChronicIllness

New in Epilepsia Open – December 7, 2025
mailchi.mp/ilae/epileps...

Subscribe - eepurl.com/iLSrNc

#epilepsy #epilepsiaopen #ILAE #EpilepsyResearch #NewInEpilepsy #JustPublished #LatestResearch

New in Epilepsia – December 6, 2025
mailchi.mp/ilae/new-art...

Subscribe - eepurl.com/iLSrNc

#epilepsy #epilepsia #ILAE #EpilepsyResearch #NewInEpilepsy #JustPublished #LatestResearch

Day two brought incredible momentum at the #AES2025 Annual Meeting—packed educational sessions, a vibrant exhibit hall, and powerful poster presentations driving new ideas in epilepsy science. Onward!

#NeuroTwitter #EpilepsyResearch

Elli leads the clinical strategy behind our MECP2 work at #AES2025. DM or email partnerships@citizenhealth.com.

#EpilepsyResearch #MECP2 #RealWorldEvidence

Elizabeth applies neurology expertise to MECP2 RWE at #AES2025. DM or email partnerships@citizenhealth.com.

#EpilepsyResearch #MECP2 #RealWorldEvidence

Celebrating AES members whose work has been strengthened by NINDS funding! Their discoveries continue to shape the future of epilepsy research and improve lives. Grateful for 75 years of NINDS support for investigators driving progress in our field.

#AES2025 #NINDS #EpilepsyResearch

Mariah strengthens MECP2 research with clinical insight at #AES2025. DM or email partnerships@citizenhealth.com.

#EpilepsyResearch #MECP2 #RealWorldEvidence

Kelsey, RN & AES award honoree, presents MECP2 findings at #AES2025. DM or email partnerships@citizenhealth.com.

#EpilepsyResearch #MECP2 #RealWorldEvidence

Steph turns complex MECP2 data into insight at #AES2025. DM or email partnerships@citizenhealth.com to learn more.

#EpilepsyResearch #MECP2 #RealWorldEvidence
@stepheaneff.bsky.social

Ashley brings clinical expertise into MECP2 research at #AES2025. DM or email partnerships@citizenhealth.com.

#EpilepsyResearch #MECP2 #RealWorldEvidence